Post-Marketing Surveillance of Micombi Tablets Survey on the Long-term Use
NCT01050062 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1452
Last updated 2014-05-01
Summary
The survey is conducted to collect safety and effectiveness information in Hypertensive patients treated with Micombi Tablets on the long term use in daily clinical settings in Japan.
Conditions
Interventions
- DRUG
-
Telmisartan 80mg
Combination tablet
- DRUG
-
Telmisartan 40mg
Combination tablet
- DRUG
-
Hydrochlorothiazide 12.5mg
Combination tablet
Sponsors & Collaborators
-
Astellas Pharma Inc
collaborator INDUSTRY - lead INDUSTRY
Principal Investigators
-
Boehringer Ingelheim · Boehringer Ingelheim
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-01-31
- Primary Completion
- 2011-12-31
- Completion
- 2011-12-31
Countries
- Japan
Study Locations
More Related Trials
-
Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine
NCT00509470 ·Status: COMPLETED ·Phase: PHASE4
-
An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination
NCT00618774 ·Status: COMPLETED ·Phase: PHASE3
-
Combination of Telmisartan 40 mg Plus Hydrochlorothiazide (HCTZ) 12.5 mg vs. Telmisartan 40 mg Alone in Patients With Essential Hypertension Who Fail to Respond Adequately to Telmisartan Monotherapy
NCT00144222 ·Status: COMPLETED ·Phase: PHASE3
-
Survey to Assess Why People Are Not Responding to Treatment in Hypertension
NCT01071681 ·Status: COMPLETED
-
Add-on to Micamlo BP Trial
NCT01975246 ·Status: COMPLETED ·Phase: PHASE3
-
Nice Morning- Safety and Efficacy Observational Study of Telmisartan in Hypertensive Patients in Multicenters
NCT00615108 ·Status: COMPLETED
-
Post-Marketing Surveillance of Micardis® (Telmisartan) in Patients With Hypertension
NCT02242838 ·Status: COMPLETED
-
A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension
NCT00133185 ·Status: COMPLETED ·Phase: PHASE3
-
Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus Amlodipine
NCT01911780 ·Status: COMPLETED ·Phase: PHASE3
-
Telmisartan and Hydrochlorothiazide Antihypertensive Treatment Study in High Sodium Intake Population
NCT02255253 ·Status: COMPLETED ·Phase: NA
-
Micardis® in Patients With Essential Hypertension
NCT02187705 ·Status: COMPLETED
-
J-TARGET,Japanese Telmisartan Study for Antihypertensive Good Effect in Long Term Observation
NCT00659581 ·Status: COMPLETED
-
Comparison in Japan T80/A5 (Telmisartan 80 mg and Amlodipine 5 mg) and T40/A5 (Telmisartan 40 mg and Amlodipine 5 mg)
NCT01286558 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics of Different Formulations of Telmisartan, Amlodipine, and Hydrochlorothiazide (HCTZ) in Japanese Healthy Male Volunteers
NCT02183675 ·Status: COMPLETED ·Phase: PHASE1
-
Open Label Study Telmisartan and Amlodipine in Hypertension
NCT00614380 ·Status: COMPLETED ·Phase: PHASE3
-
Filtered Trial for Amlodipine Non-responder
NCT00558064 ·Status: COMPLETED ·Phase: PHASE3
-
A Bioequivalence Study Between Telmione 80 mg and Micardis 80 mg in Healthy Adult Volunteers
NCT05223101 ·Status: UNKNOWN ·Phase: PHASE1
-
26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension
NCT00624052 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Efficacy and Tolerability of Micardis® / MicardisPlus® Under Usual Daily-practice Prescribing in Patients With Hypertension
NCT02242383 ·Status: COMPLETED
-
Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice
NCT03205137 ·Status: WITHDRAWN
-
Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension
NCT00257491 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
NCT04518293 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study to Investigate the Efficacy, Safety, Tolerability and the Effect on Quality of Life of Telmisartan (Micardis) and Telmisartan With HCTZ (Micardis Plus) in Patients With Hypertension
NCT00904215 ·Status: COMPLETED
-
Telmisartan 80mg Non-responder Trial
NCT01222520 ·Status: COMPLETED ·Phase: PHASE3
-
INTERVENCION Trial
NCT02373163 ·Status: COMPLETED ·Phase: PHASE4